Publications by authors named "Philip Buttery"

Claim this Profile
T
The future of gene therapy for Parkinson's disease.
Roger A Barker, Philip C Buttery

Lancet Neurol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blepharospasm Secondary to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson Disease: Clinical Characteristics and Management Outcomes.
Michelle A Ting, Alexandra I Manta, Emma Samia-Aly, Michelle Lai, Emanuel R de Carvalho, Philip Buttery

J Neuroophthalmol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-specific interventions: The use of cell and gene therapies for Parkinson disease.
Roger A Barker, Philip C Buttery

Handb Clin Neurol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?
Philip C Buttery, Roger A Barker

Neurotherapeutics· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease.
Stéphane Palfi, Jean Marc Gurruchaga, Hélène Lepetit, Katy Howard, G Scott Ralph, Philip C Buttery

Hum Gene Ther Clin Dev· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?
Philip C Buttery, Roger A Barker

J Comp Neurol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial.
Stéphane Palfi, Jean Marc Gurruchaga, G Scott Ralph, Helene Lepetit, Sonia Lavisse, Philip C Buttery

Lancet· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep brain stimulation: eye movements reveal anomalous effects of electrode placement and stimulation.
Chrystalina A Antoniades, Philip Buttery, James J FitzGerald, Roger A Barker, Roger H S Carpenter

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rac GTPase-activating protein (Rac GAP) α1-Chimaerin undergoes proteasomal degradation and is stabilized by diacylglycerol signaling in neurons.
Jamie R K Marland, DingXin Pan, Philip C Buttery

J Biol Chem· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diacylglycerol-binding protein alpha1-chimaerin regulates dendritic morphology.
Philip Buttery, Asim A Beg, Ben Chih, Arkady Broder, Carol A Mason

Proc Natl Acad Sci U S A· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Choreic syndrome and coeliac disease: a hitherto unrecognised association.
Anthony C Pereira, Mark J Edwards, Philip C Buttery, Christopher H Hawkes, Niall P Quinn

Mov Disord· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintaining stability in the face of change.
Philip Buttery, Carol Mason

Nat Neurosci· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis